Godsey & Gibb Inc. Has $1.35 Million Stake in Procter & Gamble Company (The) $PG

Godsey & Gibb Inc. lessened its holdings in shares of Procter & Gamble Company (The) (NYSE:PG) by 2.4% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 8,477 shares of the company’s stock after selling 205 shares during the period. Godsey & Gibb Inc.’s holdings in Procter & Gamble were worth $1,351,000 at the end of the most recent quarter.

A number of other large investors have also added to or reduced their stakes in PG. Nova Wealth Management Inc. purchased a new position in shares of Procter & Gamble in the 1st quarter worth approximately $26,000. Signature Resources Capital Management LLC boosted its stake in shares of Procter & Gamble by 67.9% during the 2nd quarter. Signature Resources Capital Management LLC now owns 178 shares of the company’s stock valued at $28,000 after purchasing an additional 72 shares in the last quarter. Quarry LP bought a new position in Procter & Gamble during the 1st quarter valued at approximately $33,000. Mizuho Securities Co. Ltd. boosted its holdings in shares of Procter & Gamble by 566.7% during the 1st quarter. Mizuho Securities Co. Ltd. now owns 200 shares of the company’s stock valued at $34,000 after acquiring an additional 170 shares during the last quarter. Finally, RMG Wealth Management LLC purchased a new stake in shares of Procter & Gamble in the 2nd quarter worth $37,000. Institutional investors own 65.77% of the company’s stock.

Insider Activity at Procter & Gamble

In other news, COO Shailesh Jejurikar sold 13,039 shares of the firm’s stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total transaction of $2,050,643.53. Following the completion of the transaction, the chief operating officer directly owned 28,036 shares in the company, valued at $4,409,221.72. This trade represents a 31.74% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Marc S. Pritchard sold 9,849 shares of Procter & Gamble stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total transaction of $1,548,952.23. Following the transaction, the insider owned 182,422 shares of the company’s stock, valued at $28,689,507.94. This represents a 5.12% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 149,763 shares of company stock worth $23,421,279 in the last three months. 0.20% of the stock is owned by company insiders.

Procter & Gamble Stock Performance

PG opened at $150.47 on Tuesday. Procter & Gamble Company has a 52-week low of $149.91 and a 52-week high of $180.43. The stock has a 50-day moving average of $155.38 and a 200-day moving average of $159.84. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.49 and a current ratio of 0.70. The company has a market cap of $352.17 billion, a PE ratio of 23.11, a price-to-earnings-growth ratio of 4.02 and a beta of 0.36.

Procter & Gamble (NYSE:PG) last announced its quarterly earnings data on Tuesday, July 29th. The company reported $1.48 earnings per share for the quarter, topping the consensus estimate of $1.42 by $0.06. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The company had revenue of $20.89 billion for the quarter, compared to analyst estimates of $20.79 billion. During the same quarter last year, the firm earned $1.40 EPS. Procter & Gamble’s revenue for the quarter was up 1.7% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, equities research analysts forecast that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of research analysts have recently commented on PG shares. BNP Paribas reaffirmed an “outperform” rating and set a $177.00 target price on shares of Procter & Gamble in a research note on Friday, August 15th. Wells Fargo & Company decreased their target price on Procter & Gamble from $173.00 to $170.00 and set an “overweight” rating on the stock in a research report on Thursday, September 25th. BNP Paribas Exane lowered their price objective on shares of Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating for the company in a research note on Tuesday, September 23rd. Barclays dropped their target price on Procter & Gamble from $164.00 to $153.00 and set an “equal weight” rating on the stock in a report on Wednesday, October 1st. Finally, UBS Group set a $180.00 price objective on Procter & Gamble and gave the stock a “buy” rating in a report on Wednesday, July 30th. Eleven investment analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $173.11.

Procter & Gamble Company Profile

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.